POZEN Logo
Print Page   Close Window

Press Release

POZEN Inc. CEO to Present at the U.S. Bancorp Piper Jaffray Health Care Conference

CHAPEL HILL, N.C., Jan. 24 /PRNewswire-FirstCall/ -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, announced that John R. Plachetka, Pharm. D., the company's chairman, president and chief executive officer, will make a presentation to investors and financial analysts during the U.S. Bancorp Piper Jaffray Health Care Conference. The presentation is scheduled for Tuesday, January 29, 2002 at 11:30 a.m. EST at the Pierre Hotel in New York. The presentation will also be broadcast live through the Internet and will remain archived for 30 days. The webcast information is as follows.

Webcast Location for Real Player: http://www.on24.com/clients/piperjaffray/conference_020129/index.html?presente r=pozeninc&format=rmmulti

Webcast Location for Windows Media Player: http://www.on24.com/clients/piperjaffray/conference_020129/index.html?presente r=pozeninc&format=wmmulti

North Carolina-based POZEN Inc. is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. POZEN's initial focus is on developing products for migraine therapy, a global market expected to exceed $2.6 billion this year. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."

POZEN is on the Internet at www.pozen.com

CONTACT:
Matt Czajkowski
Chief Financial Officer, of POZEN
+1-919-913-1040
or
General Inquiries
Kathy Brunson of FRB Weber Shandwick
+1-312-640-6696